Prognosis of occult breast carcinoma presenting as isolated axillary nodal metastasis

Oncology

Volumn 71, Issue 5-6, 2007, Pages 456-459

  Varadarajan, Ramya ^b   Edge, Stephen B ^a   Yu, Jihnhee ^a   Watroba, Nancy ^a   Janarthanan, Bagi R ^a,c  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROCHESTER GENERAL HOSPITAL   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Breast cancer, occult; Breast conservation

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; LETROZOLE; METHOTREXATE; TAMOXIFEN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL FEATURE; ECHOMAMMOGRAPHY; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT CANCER; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; PROGNOSIS; RADIOTHERAPY; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, MAMMARY;

EID: 35348920806     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107111     Document Type: Article

References (16)

1. Owen HW, Dockerty MB, Gray HK: Occult carcinoma of the breast. Surg Gynecol Obstet 1954;98:302-308.
2. Patel J, Nemoto T, Rosner D, Dao TL, Pickren JW: Axillary lymph node metastasis from an occult breast cancer. Cancer 1981;47:2923-2927.
3. Rosen PP: Axillary lymph node metastases in patients with occult noninvasive breast carcinoma. Cancer 1980;46:1298-1306.
4. Tench DW, Page DL: The Breast: Comprehensive Management of Benign and Malignant Diseases, vol 2, ed. 2. Philadelphia, WB Saunders, 1998, pp 1447-1452.
5. Abbruzzese JL, Abbruzzese MC, Hess KR, Raber MN, Lenzi R, Frost P: Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 1994;12:1272-1280.
6. Hainsworth JD, Greco FA: Management of patients with cancer of unknown primary site. Oncology (Williston Park) 2000;14:563-574.
7. Baron PL, Moore MP, Kinne DW, Candela FC, Osborne MP, Petrek JA: Occult breast cancer presenting with axillary metastases: updated management. Arch Surg 1990;125:210-214.
8. Fortunato L, Sorrento JJ, Golub RA, Cantu R: Occult breast cancer: a case report and review of the literature. NY State J Med 1992;92:555-557.
9. Ellerbroek N, Holmes F, Singletary E, Evans H, Oswald M, McNeese M: Treatment of patients with isolated axillary nodal metastases from an occult primary carcinoma consistent with breast origin. Cancer 1990;66:1461-1467.
10. Hainsworth JD, Greco FA: Treatment of patients with cancer of an unknown primary site. N Engl J Med 1993;329:257-263.
11. Morrow M, Schmidt RA, Bucci C: Breast conservation for mammographically occult carcinoma. Ann Surg 1998;227:502-506.
12. Halsted W: The results of radical operations for the cure of carcinoma of the breast. Ann Surg 1907;46:1-19.
13. Stomper PC, Waddell BE, Edge SB, Klippenstein DL: Breast MRI in the evaluation of patients with occult primary breast carcinoma. Breast J 1999;5:230-234.
14. Knapper WH: Management of occult breast cancer presenting as an axillary metastasis. Semin Surg Oncol 1991;7:311-313.
15. Vlastos G, Jean ME, Mirza AN, et al: Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases. Ann Surg Oncol 2001;8:425-431.
16. Clark GM, Osborne CK, McGuire WL: Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer. J Clin Oncol 1984;2:1102-1109.